Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $5 to $3.
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $5 to $3.